The American Journal of Managed Care® and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care
The Oncology Institute (NASDAQ: TOI) and the American Journal of Managed Care® (AJMC) are partnering to co-host a symposium on value-based cancer care on October 24, 2024, in Miami, Florida. The event is part of AJMC's Institute for Value-Based Medicine (IVBM), a leading forum for expert insights on implementing value-based care in oncology and population health.
The symposium will feature panel discussions with healthcare professionals, including physicians, practice administrators, and payors, focusing on key learnings and emerging opportunities. Dr. Daniel Virnich, CEO of The Oncology Institute, will chair the event. Other TOI executives moderating panels include Dr. Yale Podnos (CMO), Jordan McInerney (CDO), and Ray Parzik (VP).
L'Istituto di Oncologia (NASDAQ: TOI) e l'American Journal of Managed Care® (AJMC) stanno collaborando per co-organizzare un simposio su cure oncologiche basate sul valore il 24 ottobre 2024, a Miami, Florida. L'evento fa parte dell'Istituto per la Medicina Basata sul Valore (IVBM) di AJMC, un forum di primo piano per approfondimenti esperti sull'implementazione delle cure basate sul valore nell'oncologia e nella salute della popolazione.
Il simposio includerà discussioni di panel con professionisti del settore sanitario, tra cui medici, amministratori di studi e pagatori, con un focus su apprendimenti chiave e opportunità emergenti. Il Dr. Daniel Virnich, CEO dell'Istituto di Oncologia, presiederà l'evento. Altri dirigenti di TOI che modereranno i panel includono il Dr. Yale Podnos (CMO), Jordan McInerney (CDO) e Ray Parzik (VP).
El Instituto de Oncología (NASDAQ: TOI) y el American Journal of Managed Care® (AJMC) se están asociando para coorganizar un simposio sobre cuidado del cáncer basado en el valor el 24 de octubre de 2024, en Miami, Florida. El evento es parte del Instituto de Medicina Basada en el Valor (IVBM) de AJMC, un foro líder para obtener información de expertos sobre la implementación de atención basada en el valor en oncología y salud pública.
El simposio contará con discusiones en panel con profesionales de la salud, incluidos médicos, administradores de prácticas y pagadores, centrándose en aprendizajes clave y oportunidades emergentes. El Dr. Daniel Virnich, CEO del Instituto de Oncología, presidirá el evento. Otros ejecutivos de TOI que moderarán los paneles incluyen al Dr. Yale Podnos (CMO), Jordan McInerney (CDO) y Ray Parzik (VP).
온콜로지 연구소(NASDAQ: TOI)와 미국 관리 치료 저널(AJMC)이 협력하여 2024년 10월 24일 플로리다주 마이애미에서 가치 기반 암 치료에 대한 심포지엄을 공동 개최합니다. 이 행사는 AJMC의 가치 기반 의학 연구소(IVBM)의 일환으로, 종양학 및 인구 건강 분야에서 가치 기반 치료를 구현하는 데 대한 전문가 통찰을 제공하는 주요 포럼입니다.
심포지엄은 의료 전문가들, 의사, 진료소 관리자, 지불자들이 참여하는 패널 토론으로 구성되어 있으며, 주요 학습 내용 및 새로운 기회에 대해 논의할 예정입니다. 온콜로지 연구소의 CEO인 다니엘 비르니히 박사가 행사를 주재할 예정입니다. 패널을 진행하는 TOI의 다른 경영진으로는 예일 포드노스 박사(CMO), 조던 맥이너니(CDO), 레이 파르직(VP)이 포함됩니다.
L'Institut d'Oncologie (NASDAQ: TOI) et l'American Journal of Managed Care® (AJMC) s'associent pour co-organiser un symposium sur les soins du cancer basés sur la valeur le 24 octobre 2024, à Miami, en Floride. Cet événement fait partie de l'Institut pour la Médecine Basée sur la Valeur (IVBM) de l'AJMC, un forum de premier plan pour des aperçus d'experts sur la mise en œuvre des soins basés sur la valeur en oncologie et dans la santé de la population.
Le symposium proposera des discussions en panel avec des professionnels de la santé, y compris des médecins, des administrateurs de pratiques et des payeurs, axées sur les principales leçons et les nouvelles opportunités. Le Dr. Daniel Virnich, PDG de l'Institut d'Oncologie, présidera l'événement. D'autres dirigeants de TOI qui animeront les panels incluent le Dr. Yale Podnos (CMO), Jordan McInerney (CDO) et Ray Parzik (VP).
Das Oncology Institute (NASDAQ: TOI) und das American Journal of Managed Care® (AJMC) arbeiten zusammen, um am 24. Oktober 2024 in Miami, Florida, ein Symposium über wertbasierte Krebsversorgung auszurichten. Die Veranstaltung ist Teil des Instituts für wertbasierte Medizin (IVBM) von AJMC, einem führenden Forum für Experteneinblicke zur Implementierung wertbasierter Versorgung in der Onkologie und der Bevölkerungsgesundheit.
Das Symposium wird Podiumsdiskussionen mit Gesundheitsfachleuten, einschließlich Ärzten, Praxismanagern und Zahlenden, beinhalten, die sich auf wichtige Erkenntnisse und aufkommende Möglichkeiten konzentrieren. Dr. Daniel Virnich, CEO des Oncology Institute, wird die Veranstaltung leiten. Andere TOI-Führungskräfte, die die Panels moderieren, sind Dr. Yale Podnos (CMO), Jordan McInerney (CDO) und Ray Parzik (VP).
- Partnership with AJMC to co-host a high-profile symposium on value-based cancer care
- Participation in a premier forum for sharing insights on value-based care implementation
- Opportunity to showcase TOI's expertise and leadership in the field of oncology
- None.
CERRITOS, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Today, the Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) shared its partnership with the American Journal of Managed Care® (AJMC) to co-host a symposium focused on value-based cancer care. The event will take place on October 24, 2024, in Miami, Florida, as part of AJMC’s Institute for Value-Based Medicine (IVBM).
The IVBM serves as a premier forum where leading expert faculty share their insights and experiences in implementing value-based care for oncology and population health stakeholders. Attendees can expect dynamic panel discussions featuring a diverse range of healthcare professionals, including physicians, practice administrators, and payors, addressing key learnings and emerging opportunities in the field.
The symposium will be chaired by Dr. Daniel Virnich, Chief Executive Officer of The Oncology Institute. Key TOI executives moderating panels include Chief Medical Officer, Dr. Yale Podnos, Chief Development Officer Jordan McInerney, and Vice President, Ray Parzik.
For more information and to register for this event, please contact events@mjhevents.com.
About The Oncology Institute
Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of over 1.8 million patients including clinical trials, transfusions, and other services traditionally associated with the most advanced care delivery organizations. With over 120 employed clinicians and more than 700 teammates in over 70 clinic locations, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.
About the American Journal of Managed Care
The American Journal of Managed Care® (AJMC®) is a leader in managed care research, offering actionable insights and peer perspectives through our leading peer-reviewed journals, AJMC®, The American Journal of Accountable Care®, and AJMC®’s Evidence-Based Oncology™. In addition, AJMC® provides commentary and the latest news through other platforms, including AJMC.com, the Managed Care Cast podcast, and best-in-class video content. AJMC® keeps industry leaders on the forefront of health policy by sharing research relevant to industry decision makers. Our digital platform, AJMC.com, distributes health care news to leading stakeholders across a variety of media, including peer-to-peer video interviews, podcasts, conference coverage, interactive resources, and more. Our live events bring together industry thought leaders to exchange insights and perspectives on the evolving health care landscape.
Contacts
Investors at Solebury Strategic Communications
investors@theoncologyinstitute.com
FAQ
When and where is The Oncology Institute (TOI) co-hosting the value-based cancer care symposium?
Who is chairing the TOI and AJMC co-hosted symposium on value-based cancer care?
Which TOI executives are moderating panels at the value-based cancer care symposium?
What is the focus of the symposium co-hosted by TOI and AJMC?
